SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse current Australian managed funds0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived fundsor use SEARCH

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

REVA MEDICAL, INC (RVA)

Listed on ASX ( $0.490 +0.030 +6.52%)

Former (or subsequent) names

Shareholder links

Our website ranking of RVA:
(4 out of 5)

COMPANY WEBSITE:

RVA website

RVA email

RVA investorRelations

RVA announcements

RVA directors

REGISTRY:
Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000
Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: c/o Buchan Pty. Ltd. (â€œBuchanâ€) Suite 4, Level 14 6 Oâ€™Connell Street Sydney, NSW 2000
Tel: (858) 966-3000 Fax: (858) 966-3099

Date first listed: 23/12/2010
Company Secretary: Katrina Thompson
Sector: Health Care Equipment & Services Industry Group:
Activities: Development of medical devices, specifically bioresorbable stent products

News & Events

Expand this box to read and print

listed entity carried for record purposes only

23/12/2010

ASX Announcements (courtesy of ASX)

Date	Price sens.	Headline	Pages	PDF
Date	Price sens.	Headline	Pages	PDF	Edited text*
30/01/2015		Appendix 4C - quarterly	7	PDF	-
29/01/2015		Dr. Ross Breckenridge Appointed to Board of Directors	2	PDF	-
16/01/2015		Presentation at J.P. Morgan Healthcare Conference	27	PDF	-
12/01/2015		REVA to Present at J.P. Morgan Healthcare Conference	1	PDF	-
22/12/2014		Change of Auditors	1	PDF	-
05/12/2014		Change in Registered Office	1	PDF	-
04/12/2014		REVA Implants First Patients with Fantom Scaffold	2	PDF	-
26/11/2014		Change of Director's Interest Notice	4	PDF	-
21/11/2014		REVA Closes Financing	2	PDF	-
14/11/2014		Appendix 3B	12	PDF	-
07/11/2014		Quarterly Report on Form 10-Q	32	PDF	-
05/11/2014		Notice of Briefing Call	2	PDF	-

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Directors' share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NATURE	NUMBER	PRICE	AMOUNT
21/11/2014	Robert Stockman	On market CDIs	305,500	$0.360	$109,980
13/12/2013	Gordon Nye	On market CDIs	96,000	$0.520	$49,920
10/12/2013	Robert Stockman	On market CDIs	115,000	$0.492	$56,557
10/12/2013	Robert Thomas	On market CDIs	100,000	$0.460	$46,039
13/09/2012	Robert Thomas	On market CDIs	30,000	$0.515	$15,450

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Robert Stockman	Chairman, CEO	01/12/1999
Katrina Thompson	CFO
Ross Breckenridge	Non Exec Director	29/01/2015
Robert Thomas	Director	28/07/2010
Gordon Nye	Director	16/05/2001
Anne Keating	Director	01/10/2010
Brian Dovey	Director	12/06/2001

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION
James Schiro	Director	09/11/2010	25/07/2014